C3.AI Faces Questions After Two Revenue Declines in 2026
C3.AI reports two consecutive quarterly revenue declines, forcing investors to reassess its enterprise AI strategy as...
This analysis highlights how long-term returns vary across index funds, emphasizing the impact on portfolio resilience.
28,357 articlesC3.AI reports two consecutive quarterly revenue declines, forcing investors to reassess its enterprise AI strategy as...
Cisco’s latest quarterly results show a robust demand for AI infrastructure. The company boosts its AI targets and or...
As Tesla prepares for its July 22 report, investors are focused on margin expansion, software and services momentum, ...
Salesforce posted a stronger-than-expected quarter, delivering an EPS beat and stronger cash flow. The company unveil...
Quantum names showed a broad pullback after a sharp rally, with IonQ down about 7% and D-Wave slipping near 8% as inv...
The CLARITY Act moves toward a Senate floor vote, potentially codifying XRP’s regulatory status. This piece breaks do...
Rocket Lab posted solid Q4 FY2025 revenue above estimates, while warning that the Neutron program faces a timeline sh...
As AI and HPC demand accelerates, investors are shifting away from Intel toward foundry and lithography peers. This p...
A single hedge fund exit can move a stock as much as a major earnings beat. This guide breaks down a $34 million TDS ...
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
U.S. equities fell after inflation data exceeded expectations and AI disruption fears grew. Tech-led losses and risin...
Investors buzzed as metals company stock rocketed higher on regulatory progress and strong demand signals for battery...